← back to search

Mohamed H. Shahin

Pfizer (United States) · US
Area of research
Pharmacology · Molecular Biology
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Metabolomics and Mass Spectrometry Studies, Hormonal Regulation and Hypertension, and Statistical Methods in Clinical Trials.
h-index
18
citations
1,159
works
62
NIH funding
primary concept
email

Recent publications

Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals
Clinical Pharmacology & Therapeutics 2018cited by 32position: middledoi
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
Journal of the American Heart Association 2017cited by 21position: firstdoi
A Genetic Response Score for Hydrochlorothiazide Use
Hypertension 2016cited by 27position: firstdoi
Association of Branched and Aromatic Amino Acids Levels with Metabolic Syndrome and Impaired Fasting Glucose in Hypertensive Patients
Metabolic Syndrome and Related Disorders 2015cited by 36position: middledoi
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
The Lancet 2013cited by 275position: middledoi
VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians
Thrombosis and Haemostasis 2013cited by 32position: firstdoi
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis
Clinical Pharmacology & Therapeutics 2012cited by 68position: middledoi

Grants

U.S.-Egypt Workshop: Pavement Management
NSF9810989$29,7501998–2002PIRePORTER

Frequent collaborators

Julie A. Johnson · University of Chicago4 papers (2013–2017)Arlene B. Chapman · Deakin University3 papers (2015–2017)Reginald F. Frye · University of Tennessee Health Science Center3 papers (2015–2017)Rhonda M. Cooper‐DeHoff · University of Florida3 papers (2015–2017)Yan Gong · Nanjing Medical University3 papers (2015–2017)John G. Gums · University of Florida3 papers (2015–2017)Stephen T. Turner · Monash Institute of Medical Research3 papers (2015–2017)Amber L. Beitelshees · Center for Genomic Science3 papers (2015–2017)Timothy J. Garrett · University of Florida2 papers (2015–2016)Rima Kaddurah‐Daouk · Duke University2 papers (2016–2017)Eric Boerwinkle · Training Programs in Epidemiology and Public Health Interventions Network2 papers (2016–2017)Alison A. Motsinger‐Reif · North Carolina State University2 papers (2016–2017)Daniel M. Rotroff · Cleveland Clinic2 papers (2016–2017)Oliver Fiehn · West Coast University2 papers (2016–2017)Liming Weng · China General Nuclear Power Corporation (China)1 papers (2015–2015)Sherief Khalifa · American University in Cairo1 papers (2013–2013)Howard L. McLeod · Intermountain Healthcare1 papers (2013–2013)Minoli A. Perera · Northwestern Medicine1 papers (2013–2013) · 1 papers (2013–2013)Rebecca Baillie · Rosa (United States)1 papers (2017–2017)